Drug Landscape ›
Generic A ›
Regulatory · United States
Marketing authorisation
FDA
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
Window: 20 April 2025 – 20 April 2026
Total reports: 6
Most-reported reactions
Abdominal Pain Upper — 1 report (16.67%) Diarrhoea — 1 report (16.67%) Ill-Defined Disorder — 1 report (16.67%) Influenza Like Illness — 1 report (16.67%) Nausea — 1 report (16.67%) Vomiting — 1 report (16.67%)
Source database →
Generic A in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Generic A approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for Generic A in United States?
University of Florida is the originator. The local marketing authorisation holder may differ — check the official source linked above.